famotidine has been researched along with Carcinoma, Ductal, Breast in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current use of H(2) blockers overall, cimetidine, and famotidine was not associated with an increased risk of either invasive ductal or invasive lobular breast cancer." | 3.74 | Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer. ( Daling, JR; Li, CI; Malone, KE; Mathes, RW; Porter, PL, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathes, RW | 1 |
| Malone, KE | 1 |
| Daling, JR | 1 |
| Porter, PL | 1 |
| Li, CI | 1 |
1 other study available for famotidine and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.
Topics: Aged; Anti-Ulcer Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Contr | 2008 |